Practo in talks to acquire ‘HealthPlix’ for $30 Million

Practo was reported to be in talks to acquire healthtech SaaS startup HealthPlix for an estimated $25 million to $30 million, in a deal that could strengthen Practo’s enterprise healthcare software business. However, hours after the initial report was published, HealthPlix co-founder Sandeep Gudibanda publicly denied the acquisition speculation, saying there was “no truth” to reports of a deal and that the company remains independent and focused on expansion.

The conflicting statements make the proposed transaction uncertain. Inc42 reported that due diligence was underway and that the deal could close within weeks, citing unnamed sources. HealthPlix subsequently said that no acquisition was under discussion and that it was actively expanding, particularly in the US market.

Practo-HealthPlix Deal Reports

According to the original report, Practo was negotiating to acquire HealthPlix at a valuation of between $25 million and $30 million.

The proposed acquisition would have strengthened Practo’s business-to-business healthcare technology operations by adding HealthPlix’s electronic medical records (EMR) platform and clinical workflow software to Practo’s existing offerings.

Practo operates a consumer-facing healthcare platform that allows patients to discover doctors, book appointments, consult physicians online, order medicines and arrange diagnostic services. It also provides practice-management software for healthcare providers.

HealthPlix, meanwhile, focuses primarily on doctors and healthcare providers through software designed to digitise clinical workflows.

Reported Deal Snapshot

Particular	Details
Potential acquirer	Practo
Target	HealthPlix
Reported deal value	$25 million–$30 million
Status	Reported talks; disputed by HealthPlix
Reported process	Due diligence underway
Potential rationale	Expand enterprise healthcare software
HealthPlix focus	EMR and clinical workflow software
HealthPlix latest funding	$22 million Series C in 2023
Last reported valuation	About $60 million

HealthPlix Denies Acquisition Talks

The most important development is HealthPlix’s denial.

Hours after Inc42 published its original report, co-founder Sandeep Gudibanda said HealthPlix was not in talks to be acquired by Practo.

He described the reports as speculation and said HealthPlix remained an independent company. He also said the startup was in expansion mode and was actively growing its footprint in the US market.

The statement means that the reported $25 million-$30 million transaction should not be treated as a confirmed acquisition.

Practo had not responded to Inc42’s questions at the time of the original publication.

Why HealthPlix Would Be Strategically Important for Practo

If an acquisition were to happen, HealthPlix’s technology could complement Practo’s consumer healthcare platform.

Practo has historically operated at the intersection of patients and healthcare providers. HealthPlix would add deeper software infrastructure for doctors, particularly around electronic medical records and clinical workflows.

The combination could allow Practo to strengthen its enterprise healthcare technology business rather than relying primarily on patient-facing services.

Potential Strategic Fit

Practo: Patient discovery, appointments, consultations, medicines, diagnostics and practice management.

HealthPlix: Electronic medical records, digital patient records and clinical workflow management.

Together, the businesses could potentially create a broader healthcare technology platform connecting patients, doctors, clinics and healthcare data.

What HealthPlix Does

Founded in 2014, HealthPlix provides EMR software that allows doctors to maintain digital patient records, manage consultations and streamline clinical workflows. The company was founded by Sandeep Gudibanda, Raghuraj Sunder Raju and Prasad Basavaraj.

Its software is designed primarily around the needs of healthcare professionals rather than consumers.

Digital medical records can help doctors maintain patient histories, organise consultations and manage information across multiple visits.

For healthcare providers, these systems can become an important part of daily operations because medical data needs to be accessible and structured throughout the patient journey.

HealthPlix Raised $22 Million in 2023

HealthPlix last raised $22 million through a combination of equity and debt in its Series C round in 2023.

The funding round was led by Avataar Venture Partners and SIG Venture Capital. Other investors in the company include Lightspeed Venture Partners, JSW Ventures and Kalaari Capital.

HealthPlix was last reported to have a valuation of approximately $60 million.

If the reported $25 million-$30 million acquisition price were accurate, it would represent a substantial discount to that earlier valuation. However, because HealthPlix has denied that acquisition talks are taking place, the reported transaction value should be treated only as an unconfirmed figure.

HealthPlix Has Been Restructuring

HealthPlix underwent a significant restructuring in 2024, when it laid off approximately 100 employees, equivalent to around 25% of its workforce at the time.

The company described the layoffs as part of restructuring and its annual performance-review process.

Such restructuring can allow a SaaS company to reduce operating costs and focus resources on its most commercially promising products and markets.

The startup’s latest statement indicates that it is now focused on expansion rather than pursuing an exit.

US Expansion Is Becoming Important

HealthPlix’s co-founder specifically highlighted the company’s expansion in the US market while denying the acquisition reports.

The US healthcare market represents a significant opportunity for healthcare software companies because providers increasingly rely on digital systems for patient records, workflows and administrative processes.

However, entering the US market also brings complex regulatory, security and integration requirements.

HealthPlix’s decision to focus on US expansion suggests that international growth may be an important part of its current strategy.

Practo Is Preparing for a Potential IPO

The reported acquisition talks also came at an important point for Practo.

Practo is preparing to raise around $120 million in a potential pre-IPO funding round, according to Inc42’s earlier reporting. The proposed round was reportedly being discussed at a post-money valuation of approximately $700 million.

An acquisition of HealthPlix could potentially strengthen Practo’s enterprise software business ahead of such a fundraising exercise.

A broader software portfolio could help Practo demonstrate greater diversification and recurring enterprise revenue.

However, there is currently no confirmation that Practo intends to complete the HealthPlix transaction.

Practo’s Business Has Expanded Beyond Patient Bookings

Practo began as a healthcare discovery and appointment platform but has expanded into several areas of digital healthcare.

Its services include:

• Doctor discovery
• Appointment booking
• Online consultations
• Medicine ordering
• Diagnostic test scheduling
• Practice-management software
• Healthcare clinics

The company has also expanded internationally.

Practo entered the UAE market and has launched a US pilot, where it claims to have onboarded more than 200,000 doctors and reached an annual GMV run rate above $75 million.

Practo’s Funding History

Practo has raised nearly $230 million over its lifetime, according to Inc42.

Its investors have included Tencent, Peak XV Partners, Z47 Partners, Sofina, CapitalG and other investors. The company’s most recent reported funding round was a $32 million raise in 2020.

The company is now positioning itself for a potential public-market journey.

A stronger enterprise software business could become an important component of that strategy.

Healthcare SaaS Is Becoming More Important

The potential deal reflects the broader growth of healthcare SaaS in India.

Healthcare providers increasingly need software to manage:

• Patient records
• Appointment schedules
• Billing
• Clinical workflows
• Diagnostics
• Telemedicine
• Prescriptions
• Data analytics

Cloud-based software can allow hospitals and doctors to digitise these processes without building their own technology infrastructure.

This creates opportunities for specialised healthcare SaaS companies such as HealthPlix.

AI Could Transform Healthcare Software

Artificial intelligence is also becoming increasingly important in healthcare technology.

Future healthcare software could use AI for:

• Clinical documentation
• Medical-record summarisation
• Patient-history analysis
• Administrative automation
• Appointment management
• Decision-support tools
• Patient communication

For Practo, adding deeper clinical software capabilities could potentially provide a foundation for integrating AI into provider workflows.

However, healthcare AI also requires strong safeguards around patient data, accuracy and clinical responsibility.

The Enterprise Opportunity for Practo

Consumer healthcare platforms can generate revenue from appointments, consultations, diagnostics and other services.

Enterprise healthcare software provides a different business model.

Clinics and doctors can pay recurring subscription or service fees for software they use continuously.

This can potentially create more predictable recurring revenue and increase customer retention.

An acquisition of HealthPlix, if it were eventually confirmed, could therefore help Practo deepen its enterprise SaaS business.

Why HealthPlix’s Denial Matters

The denial substantially changes how the development should be interpreted.

The original report described an acquisition in progress, including a reported price range and due diligence.

HealthPlix’s subsequent statement says there is no acquisition discussion at all.

Until either company officially confirms a transaction, the safest conclusion is that the acquisition remains unconfirmed.

The situation also demonstrates the importance of distinguishing between reported negotiations and completed startup deals.

What Happens Next

The immediate question is whether Practo will comment on the reported negotiations.

If the company confirms talks, investors and the startup ecosystem will likely focus on the valuation, structure and strategic rationale of the transaction.

If Practo also denies the discussions, the reported acquisition would effectively remain unsubstantiated.

HealthPlix’s statement, meanwhile, suggests that the company intends to remain focused on independent expansion, particularly in the US.

What Investors Should Watch

For Practo, important developments include:

• Pre-IPO fundraising
• Valuation
• Enterprise SaaS growth
• US expansion
• Potential acquisitions
• Revenue and profitability
• Doctor and clinic adoption

For HealthPlix, investors will likely watch:

• US market expansion
• Customer growth
• Recurring SaaS revenue
• Product development
• AI integration
• Future fundraising
• Profitability

The outcome of any potential Practo transaction is only one of several factors shaping both companies’ future strategies.

Broader Industry Impact

The reported Practo-HealthPlix transaction, despite being denied by HealthPlix, highlights the increasing strategic value of healthcare SaaS platforms in India’s digital-health ecosystem.

For Practo, an EMR-focused platform would theoretically strengthen its position on the provider side of healthcare technology. For HealthPlix, continued independent expansion could allow it to build its own international SaaS business, particularly in the US market.

The broader trend is clear: healthcare technology companies are increasingly moving beyond consumer-facing appointment platforms toward software infrastructure that supports doctors, clinics and hospitals.

Looking Ahead

Practo was reportedly in talks to acquire HealthPlix for $25 million-$30 million, with the proposed transaction potentially strengthening Practo’s enterprise healthcare software business. However, HealthPlix co-founder Sandeep Gudibanda subsequently denied that any acquisition discussions were taking place, saying the company remains independent and focused on expansion, including in the US.

As a result, the reported acquisition should currently be treated as unconfirmed rather than a completed or agreed transaction. The episode nevertheless highlights the strategic importance of EMR and clinical workflow software as Practo prepares for a potential pre-IPO fundraise and expands its healthcare technology footprint. If Practo and HealthPlix eventually do combine, the deal could create a broader platform spanning patient-facing healthcare services and provider-focused enterprise software. If not, HealthPlix’s continued international expansion could make it an increasingly important independent player in healthcare SaaS.